Entity Details

Primary name PYRG1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP17812
EntryNamePYRG1_HUMAN
FullNameCTP synthase 1
TaxID9606
Evidenceevidence at protein level
Length591
SequenceStatuscomplete
DateCreated1990-08-01
DateModified2021-06-02

Ontological Relatives

GenesCTPS1

GO terms

Show/Hide Table
GOName
GO:0003883 CTP synthase activity
GO:0005524 ATP binding
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0006139 nucleobase-containing compound metabolic process
GO:0006241 CTP biosynthetic process
GO:0006541 glutamine metabolic process
GO:0015949 nucleobase-containing small molecule interconversion
GO:0016020 membrane
GO:0019856 pyrimidine nucleobase biosynthetic process
GO:0042098 T cell proliferation
GO:0042100 B cell proliferation
GO:0042493 response to drug
GO:0042802 identical protein binding
GO:0044210 'de novo' CTP biosynthetic process
GO:0097268 cytoophidium

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR004468 CTP synthaseFamilyFamily
IPR017456 CTP synthase, N-terminalDomainDomain
IPR017926 Glutamine amidotransferaseDomainDomain
IPR027417 P-loop containing nucleoside triphosphate hydrolaseFamilyHomologous superfamily
IPR029062 Class I glutamine amidotransferase-likeFamilyHomologous superfamily
IPR033828 CTP synthase GATase domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615897 OMIMImmunodeficiency 24 (IMD24)A life-threatening immunodeficiency, characterized by an impaired capacity of activated T and B cells to proliferate in response to antigen receptor-mediated activation. Patients have early onset of severe chronic viral infections, mostly caused by herpes viruses, including EBV and varicella zooster virus (VZV), and also suffer from recurrent encapsulated bacterial infections, a spectrum of infections typical of a combined deficiency of adaptive immunity. The disease is caused by variants affecting the gene represented in this entry. A unique and recessive G to C mutation probably affecting a splice donor site at the junction of intron 17-18 and exon 18 has been identified in all patients. It results in expression of an abnormal transcript lacking exon 18 and a complete loss of the expression of the protein.

Drugs

Show/Hide Table
DrugNameSourceType
DB00130 L-GlutamineDrugbanksmall molecule